Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the
blood glucose control (HbA1c) using NovoRapid® (insulin aspart) and Levemir® (insulin
detemir) after switch from human insulins for treatment of type 1 diabetes under normal
clinical practice conditions in Romania.